Isorhamnetin Downregulates MMP2 and MMP9 to Inhibit Development of Rheumatoid Arthritis through SRC/ERK/CREB Pathway
Xiaorong Liu, Shuofu Li, Wen-ya Mei, Xiang-dan Liu, Ri-bao Zhou, Xiang-dan Liu, Ri-bao Zhou
Topics & Concepts
IsorhamnetinMMP9MMP2MAPK/ERK pathwayChemistryMatrix metalloproteinaseEndocrinologyInternal medicineMedicineKinaseDownregulation and upregulationBiochemistryCancerMetastasisKaempferolAntioxidantGeneQuercetinBone Metabolism and DiseasesCytokine Signaling Pathways and InteractionsPharmacological Effects of Medicinal Plants